Tag Archives: After

CDC holding emergency meeting on heart inflammation in young males after COVID shot

The Centers for Disease Control and Prevention’s COVID-19 vaccine advisory committee will attend an emergency meeting next week to discuss higher than expected reports of heart inflammation in young males who received their second dose of the Pfizer and Moderna vaccines. The June 18 meeting will address the conditions that are very rare and have… Read More »

2nd time’s the charm? Novo Nordisk reups bid for high-dose Ozempic after March FDA snub

Novo Nordisk is back for round two with a new Ozempic dosing regimen. The diabetes specialist resubmitted to the FDA on Friday after a March snub, renewing its bid to compete with Eli Lilly’s already approved higher dose. Novo’s resubmission aims to nab an approval for a once-weekly, 2-mg dose for Ozempic, a GLP-1 drug already approved for weekly dosing at… Read More »

Stanford researchers say they won’t be silenced after criticizing Trump’s coronavirus advisor Dr. Scott Atlas

US President Donald Trump (L) listens to White House coronavirus adviser Dr. Scott Atlas speak during a press conference in the Brady Briefing Room of the White House on September 23, 2020, in Washington, DC. Mandel Ngan | AFP | Getty Images On Thursday, dozens of doctors and researchers from Stanford University emphasized that they… Read More »